AstraZeneca-Oxford COVID-19 vaccine approved in EU Reuters Jan 30, 2021 The AstraZeneca vaccine demonstrated efficacy of around 60 per cent in the trials on which the decision was based, the European…
Developing herd immunity without pharma interventions may have detrimental consequences: Choubey Press Trust of India Sep 20, 2020 Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for COVID-19…
COVID-19 resurgence expected in US as herd immunity unlikely: GlobalData EP News Bureau Aug 2, 2020 New data suggest that some hard-hit communities may be better protected for COVID-19 resurgence, while other communities are not
